Hasil Pencarian - Susanne Brakemeier
- Menampilkan 1 - 5 hasil dari 5
-
1
-
2
Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept oleh Mira Choi, Friederike Bachmann, Kaiyin Wu, Nils Lachmann, Danilo Schmidt, Susanne Brakemeier, Michael Duerr, Andreas Kahl, Kai-Uwe Eckardt, Klemens Budde, Peter Nickel
Diterbitkan 2020-08-01Dapatkan teks lengkap
Artikel -
3
Everolimus in de novo kidney transplant recipients participating in the Eurotransplant senior program: Results of a prospective randomized multicenter study (SENATOR). oleh Susanne Brakemeier, Wolfgang Arns, Frank Lehner, Oliver Witzke, Oliver Vonend, Claudia Sommerer, Anja Mühlfeld, Thomas Rath, Robert Schuhmann, Bianca Zukunft, Irena Kroeger, Martina Porstner, Klemens Budde
Diterbitkan 2019-01-01Dapatkan teks lengkap
Artikel -
4
A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients oleh Michael Duerr, Eva V. Schrezenmeier, Lukas J. Lehner, Léon Bergfeld, Petra Glander, Stephan R. Marticorena Garcia, Christian E. Althoff, Ingolf Sack, Susanne Brakemeier, Kai-Uwe Eckardt, Klemens Budde, Fabian Halleck
Diterbitkan 2019-02-01Dapatkan teks lengkap
Artikel -
5
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. oleh John J Bissler, J Chris Kingswood, Elzbieta Radzikowska, Bernard A Zonnenberg, Elena Belousova, Michael D Frost, Matthias Sauter, Susanne Brakemeier, Petrus J de Vries, Noah Berkowitz, Maurizio Voi, Severine Peyrard, Klemens Budde
Diterbitkan 2017-01-01Dapatkan teks lengkap
Artikel